Chonluten 20mg (Bioregulator)

Targeted Lung Support Through Gene Regulation

Chonluten is a short-chain peptide known for its ability to regulate gene expression, particularly in the lungs and gastrointestinal tract. This tripeptide, also referred to as T-34, plays a key role in managing inflammation, supporting antioxidant defenses, and influencing cellular repair processes in response to damage.

How Chonluten Works

Research indicates that Chonluten interacts directly with DNA to activate or suppress specific genes involved in inflammation, oxidative stress, and cell survival. It is especially active in lung tissues, where it helps restore normal mucosal function—making it a promising agent in conditions like asthma, COPD, and other chronic inflammatory lung diseases.

Key Benefits in Research Settings

• Lung Health Support: Normalizes bronchial mucosa, reduces inflammation, and regulates mucus production—potentially useful for chronic conditions like smoker’s cough or bronchitis.

• Anti-inflammatory & Antioxidant Action: Modulates genes like TNF-alpha, COX-2, HSP70, and SOD, which are associated with inflammation and oxidative damage.

• Supports Cellular Balance: Helps manage cell growth and repair by influencing proteins like c-Fos, which are vital in tissue regeneration and inflammation control.

• Potential in GI Health: Though secondary to its effects in the lungs, Chonluten may also support gastrointestinal tissues affected by inflammation.

Chonluten and Respiratory Research

During the COVID-19 pandemic, Chonluten gained attention for its anti-inflammatory properties. In research, it has been studied for improving respiratory function, especially in conditions involving low oxygen levels. It may enhance the effectiveness of other therapies in managing bronchopulmonary stress and inflammation.

Chonluten and Aging

Chonluten is also explored as a geroprotective peptide, meaning it may help delay age-related changes by supporting healthy gene expression. Studies on similar short peptides suggest they could extend lifespan, reduce tumor development, and promote cellular longevity.

Molecular Details

• Alternative Names: T-34, EDG

• CAS Number: 75007-24-8

• Molecular Weight: 319.27 g/mol

• PubChem CID: 194641

Developed Through Decades of Research

Chonluten was developed by Prof. Vladimir Khavinson, a renowned researcher in peptide bioregulation and aging. His groundbreaking work at the St. Petersburg Institute of Bioregulation and Gerontology has led to the creation of several peptide-based therapeutics and supplements used worldwide in scientific research.

For Research Use Only

Chonluten 20mg is intended strictly for educational and laboratory research purposes. It is not approved for human consumption, medical use, or application in food or cosmetics. All handling must comply with local laws and research guidelines.